Skip to main content
EJNMMI Research

Table 1 Clinical information

From: Multimodal analysis using [11C]PiB-PET/MRI for functional evaluation of patients with Alzheimer’s disease

Group

Age (years old)

Sex

VSRAD

Perfusion SPECT

MMSE

ADAS

AD (N = 27)

69 ± 12

M 13

F 14

1.86 ± 0.99

s/o DAT 14

s/o FTD 4

WNL 3

24 ± 3*

15 ± 8

CTL (N = 16)

68 ± 11

M 9

F 7

1.27 ± 0.78

–

29 ± 1

–

  1. Perfusion SPECT was performed in 21 patients using N-isopropyl-p-[123I]iodo-amphetamine (IMP)
  2. AD Alzheimer’s patients, CTL healthy controls, VSRAD voxel-based specific regional analysis system for Alzheimer’s disease, MMSE Mini-Mental State Examination, ADAS Alzheimer’s Disease Assessment Scale-Cognitive Subscale, DAT dementia of Alzheimer’s type, FTD frontotemporal dementia
  3. *P < 0.00001
Back to article page